Filtered By:
Source: The Lancet Neurology
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 249 results found since Jan 2013.
Breaking up is hard to do: tenecteplase in acute stroke
Publication date: Available online 26 February 2015 Source:The Lancet Neurology Author(s): Lee H Schwamm
Source: The Lancet Neurology - February 26, 2015 Category: Neurology Source Type: research
Screening for atrial fibrillation after stroke or TIA
Publication date: Available online 4 March 2015 Source:The Lancet Neurology Author(s): Azmil H Abdul-Rahim , Kennedy R Lees
Source: The Lancet Neurology - March 5, 2015 Category: Neurology Source Type: research
The stroke care revolution
Publication date: Available online 6 March 2015 Source:The Lancet Neurology Author(s): The Lancet Neurology
Source: The Lancet Neurology - March 6, 2015 Category: Neurology Source Type: research
Brain CT signs and the effect of alteplase after stroke
Publication date: Available online 27 March 2015 Source:The Lancet Neurology Author(s): Vincent Larrue
Source: The Lancet Neurology - March 27, 2015 Category: Neurology Source Type: research
Desmoteplase for late treatment of stroke: still in the dark
Publication date: Available online 30 April 2015 Source:The Lancet Neurology Author(s): Michael D Hill , Bijoy K Menon
Source: The Lancet Neurology - May 1, 2015 Category: Neurology Source Type: research
A call to revolutionise acute stroke care and research
Publication date: July 2015 Source:The Lancet Neurology, Volume 14, Issue 7 Author(s): Peter A G Sandercock
Source: The Lancet Neurology - June 9, 2015 Category: Neurology Source Type: research
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Publication date: Available online 23 June 2015 Source:The Lancet Neurology Background A systematic assessment of potential disease-modifying compounds for Parkinson's disease concluded that pioglitazone could hold promise for the treatment of patients with this disease. We assessed the effect of pioglitazone on the progression of Parkinson's disease in a multicentre, double-blind, placebo-controlled, futility clinical trial. Methods Participants with the diagnosis of early Parkinson's disease on a stable regimen of 1 mg/day rasagiline or 10 mg/day selegiline were randomly assigned (1:1:1) to 15 mg/day pioglitazone, 45 mg...
Source: The Lancet Neurology - June 24, 2015 Category: Neurology Source Type: research
Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasia
Publication date: August 2015 Source:The Lancet Neurology, Volume 14, Issue 8 Author(s): Fernando Pico , Julien Labreuche , Pierre Amarenco Up to 12% of patients with stroke have intracranial arterial dolichoectasia (IADE) and the basilar artery is affected in 80% of these cases. Diagnostic criteria and prognosis studies of IADE are based on basilar artery diameter, which is a good quantitative marker for the severity of the disease. The pathophysiology is largely unknown, but IADE can be viewed as a common final pathway of arterial wall response or damage in the tunica media due to various mechanisms, such as matrix met...
Source: The Lancet Neurology - July 13, 2015 Category: Neurology Source Type: research
Ischaemic stroke of undetermined cause
Publication date: Available online 27 July 2015 Source:The Lancet Neurology Author(s): Jose M Ferro
Source: The Lancet Neurology - July 28, 2015 Category: Neurology Source Type: research
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Publication date: Available online 10 August 2015 Source:The Lancet Neurology Author(s): Mike A Nalls, Cory Y McLean, Jacqueline Rick, Shirley Eberly, Samantha J Hutten, Katrina Gwinn, Margaret Sutherland, Maria Martinez, Peter Heutink, Nigel M Williams, John Hardy, Thomas Gasser, Alexis Brice, T Ryan Price, Aude Nicolas, Margaux F Keller, Cliona Molony, J Raphael Gibbs, Alice Chen-Plotkin, Eunran Suh, Christopher Letson, Massimo S Fiandaca, Mark Mapstone, Howard J Federoff, Alastair J Noyce, Huw Morris, Vivianna M Van Deerlin, Daniel Weintraub, Cyrus Zabetian, Dena G Hernandez, Suzanne Les...
Source: The Lancet Neurology - August 11, 2015 Category: Neurology Source Type: research
Peter Rothwell: aspirin(g) physician with a little stroke of genius
Publication date: September 2015 Source:The Lancet Neurology, Volume 14, Issue 9 Author(s): Adrian Burton
Source: The Lancet Neurology - August 25, 2015 Category: Neurology Source Type: research
Cranial functional (psychogenic) movement disorders
Publication date: December 2015 Source:The Lancet Neurology, Volume 14, Issue 12 Author(s): Diego Kaski, Adolfo M Bronstein, Mark J Edwards, Jon Stone Functional (psychogenic) neurological symptoms are frequently encountered in neurological practice. Cranial movement disorders—affecting the eyes, face, jaw, tongue, or palate—are an under-recognised feature of patients with functional symptoms. They can present in isolation or in the context of other functional symptoms; in particular, for functional eye movements, positive clinical signs such as convergence spasms can be triggered by the clinical examination. Alt...
Source: The Lancet Neurology - November 11, 2015 Category: Neurology Source Type: research
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data
Publication date: Available online 2 December 2015 Source:The Lancet Neurology Author(s): Margaret A Horne, Kelly D Flemming, I-Chang Su, Christian Stapf, Jin Pyeong Jeon, Da Li, Susanne S Maxwell, Philip White, Teresa J Christianson, Ronit Agid, Won-Sang Cho, Chang Wan Oh, Zhen Wu, Jun-Ting Zhang, Jeong Eun Kim, Karel ter Brugge, Robert Willinsky, Robert D Brown, Gordon D Murray, Rustam Al-Shahi Salman Background Cerebral cavernous malformations (CCMs) can cause symptomatic intracranial haemorrhage (ICH), but the estimated risks are imprecise and predictors remain uncertain. We aimed to obtain precis...
Source: The Lancet Neurology - December 3, 2015 Category: Neurology Source Type: research
Stroke in 2015: the year of endovascular treatment
Publication date: January 2016 Source:The Lancet Neurology, Volume 15, Issue 1 Author(s): Keith W Muir
Source: The Lancet Neurology - December 8, 2015 Category: Neurology Source Type: research
Human genetics shines a light on ischaemic stroke
Publication date: Available online 19 December 2015 Source:The Lancet Neurology Author(s): Benjamin F Voight, Daniel J Rader
Source: The Lancet Neurology - December 19, 2015 Category: Neurology Source Type: research
